As of 2026-03-29, the Relative Valuation of Alliance Pharma PLC (APH.L) is (20.33) GBP. This relative valuation is based on P/E multiples. With the latest stock price at 64.70 GBP, the upside of Alliance Pharma PLC based on Relative Valuation is -131.4%.
The range of the Relative Valuation is (18.92) - (21.88) GBP.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.2x - 11.2x | 9.6x |
| Forward P/E multiples | 9.7x - 12.6x | 11.2x |
| Fair Price | (18.92) - (21.88) | (20.33) |
| Upside | -129.2% - -133.8% | -131.4% |
| Date | P/E |